Docstoc

Disease Therapeutics - Global Drug Forecasts and Treatment Analysis to 2020

Document Sample
Disease Therapeutics - Global Drug Forecasts and Treatment Analysis to 2020 Powered By Docstoc
					Disease Therapeutics - Global Drug Forecasts and Treatment Analysis to 2020

http://www.aarkstore.com/search/viewresults.asp?search=DiseaseTherapeutics&PubId=&pagenum=1


the industry analysis specialist, has released its new reports” Disease Therapeutics - Global Drug
Forecasts and Treatment Analysis to 2020”. The report is an essential source of information and analysis
on the global therapeutics market. It provides comprehensive market information, highlighting the
treatment guidelines and identifying and analyzing the key trends shaping and driving the global market.
It analyzes treatment usage patterns and provides insights into the competitive landscape and the
emerging players expected to significantly alter the positions of the market leaders. The report provides
valuable insights into the pipeline products and quantifies the unmet need within the global PD
therapeutics market and as well as in the individual markets of the US and the top five countries in
Europe, highlighting opportunities for future players.

Keywords

Market forecast, revenues, unmet need, drivers, barriers, pharma, clinical trials, marketed products,
pipeline, promising drugs, future players, key companies, strategic competitor assessment, market
characterization, implications for future market, mechanism of action, oncology, cancer, treatment
guideline, target product profile, clinician's endpoints, disease overview, colorectal cancer drug sales, US
colorectal cancer market, UK colorectal cancer market, France colorectal cancer market, Germany
colorectal cancer market, Italy colorectal cancer market, Spain colorectal cancer market, Japan
colorectal cancer market, BRIC colorectal cancer market, Brazil, Russia, India, China

Related Reports

Graves’ Disease Therapeutics - Pipeline Assessment and Market Forecast to 2019 Feb 2012

http://www.aarkstore.com/reports/Graves’-Disease-Therapeutics-Pipeline-Assessment-and-Market-
Forecast-to-2019-192633.html
Scope

The report provides information on the key drivers and challenges of the Graves Disease Therapeutics
market. Its scope includes -

- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Graves Disease
Therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019.

The report provides information on the key drivers and challenges of the Graves Disease Therapeutics
market. Its scope includes -

- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Graves Disease
Therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019.
- Pipeline analysis data providing a split across the different phases, mechanisms of action being
developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic
classes.

- Analysis of the current and future competition in the seven key countries Graves Disease Therapeutics
market.

- Insightful review of the key industry drivers, restraints and challenges. Each trend is independently
researched to provide a qualitative analysis of its implications.

- Key topics covered include strategic competitor assessment, market characterization, unmet needs and
the implications for the Graves Disease Therapeutics market.

- Analysis of key recent licensing and partnership agreements in Graves Disease Therapeutics market


About Company

Market Research Reports Distributor - Aarkstore.com have vast database on market research reports,
company financials, company profiles, SWOT analysis, company report, company statistics, strategy
review, industry report, industry research to provide excellent and innovative service to our report
buyers.
Related Reports:

Parkinson's Disease Therapeutics - Global Drug Forecasts and Treatment Analysis to 2020 Feb 2012

http://www.aarkstore.com/reports/Parkinson-s-Disease-Therapeutics-Global-Drug-Forecasts-and-
Treatment-Analysis-to-2020-198860.html

This report is built using data and information sourced from proprietary databases, primary and
secondary research and in-house analysis by GlobalData’s team of industry experts.

 In 2011, the global Parkinson’s Disease (PD) therapeutics market, which includes the key markets of the
US, Japan, Germany, the UK, France, Italy, Spain, Brazil, China, India and Russia was estimated to be
worth $2,992m. During the period 2002-2011, the global PD therapeutics market grew at a Compound
Annual Growth Rate (CAGR) of 5.8%. GlobalData analysis shows that the market size was primarily
driven by two key parameters: the increase in PD prevalence due to the increase in the aging population
in the 11 key markets and the increasing cost of therapy. In 2011, the market registered a decline in the
market valuations due to the entry of generics for Mirapex (pramipexole) and higher preference for
generic ropinirole.The global PD therapeutics market is primarily served by levodopa, dopamine
agonists, Monoamine Oxidase Inhibitors (MAO-BI) and Catechol-O-Methyltransferase (COMT) inhibitors.
The market is dominated by branded products such as Boehringer Ingelheim’s
Mirapex/Mirapexin/Sifrol/MirapexER/MirapexinER (pramipexole), GlaxoSmithKline’s (GSK)
Requip/RequipXL(ropinirole),Orion/Novartis’ Stalevo/Comtan (carbidopa/levodopa/entacapone) and
Teva/Lundbeck’s Azilect/Agilect (rasagiline). In addition, a large number of generics are also available in
this market. The global PD therapeutics market is expected to grow at a modest CAGR of 2.2% and is
forecast to reach $3,650m by 2020. The modest growth rate has been attributed to patent expiries of
the major drugs, the subsequent entry of generics and the weak late stage developmental pipeline.
Gaucher’s Disease Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Jan 2012

http://www.aarkstore.com/reports/Gauchers-Disease-Therapeutics-Pipeline-Assessment-and-
Market-Forecasts-to-2018-170093.html




Fabrys Disease Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Dec 2011

Kawasaki Disease Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Dec 2011

Fabry’s Disease Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Dec 2011

Kawasaki Disease Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Dec 2011

Atherosclerosis or Coronary Artery Disease Therapeutics (CAD) - Pipeline Assessment and Market
Forecasts to 2018 Nov 2011

Periodontal Disease Therapeutics - Pipeline Assessment and Market Forecasts to 2018 Nov 2011

Rare Disease Therapeutics, Inc.-Therapeutic Competitors Report Mar 2011

Rare Disease Therapeutics, Inc.-Detailed Product Pipeline Jan 2011

Lyme disease Therapeutics - Pipeline Assessment and Market Forecasts to 2017 Dec 2010

Rare Disease Therapeutics, Inc.-Company Report April 2010



Aarkstore Enterprise
Jessica
Support Team
Mobile: +918149852585
Office: +912227453309